SMAD4 and colonic neoplasm: Loss of SMAD4 has also been shown to induce alternative ERK pathways to induce migration and invasion of colon cancer cells in vitro, to enhance liver metastasis in vivo, and to shorten the survival of metastatic tumor-bearing mice [84].